SCNI
Scinai Immunotherapeutics Ltd ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.71
-0.02 ▼ -2.68%
🌙 3월 13일 5:46 PM ET (한국 3/14 06:46)
$0.73
+0.02 ▲ +2.93%
| Index | - | P/E | - | EPS (ttm) | -12.27 | Insider Own | 2.25% | Shs Outstand | 0.00B | Perf Week | -8.92% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -11.2% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 9.61% | Short Float | 5.58% | Perf Quarter | -42.24% |
| Income | -0.01B | P/S | 0.48 | EPS this Y | - | Inst Trans | 3.65% | Short Ratio | 0.86 | Perf Half Y | -55.04% |
| Sales | 0.00B | P/B | 0.14 | EPS next 5Y | - | ROA | 24.2% | Short Interest | 0.05M | Perf YTD | -0.24% |
| Book/sh | 5.1 | P/C | 0.2 | EPS past 3/5Y | - | ROE | 138.38% | 52W High | -88.5% ($6.18) | Perf Year | -78.67% |
| Cash/sh | 3.54 | P/FCF | - | Sales past 3/5Y | - | ROIC | -73.44% | 52W Low | 15.89% ($0.61) | Perf 3Y | -96.62% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -4121.1% | Gross Margin | -177.62% | Volatility(W/M) | 9.95% 10.81% | Perf 5Y | -99.83% |
| Dividend TTM | - | EV/Sales | 4.22 | Sales Y/Y TTM | 178.82% | Oper. Margin | -394.73% | ATR (14) | 0.09 | Perf 10Y | -99.81% |
| Dividend Ex-Date | - | Quick Ratio | 1.32 | EPS Q/Q | -138.13% | Profit Margin | -679.01% | RSI (14) | 38.9 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.32 | Sales Q/Q | 64.57% | SMA20 | -10.11% ($0.79) | Beta | 1.91 | Target Price | $700 |
| Payout | - | Debt/Eq | 0.21 | Earnings | - | SMA50 | -15.35% ($0.84) | Rel Volume | 0.25 | Prev Close | $0.73 |
| Employees | 31 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | - | SMA200 | -49.61% ($1.41) | Avg Volume(3M) | 0.05M | Price | $0.71 |
| IPO | 2015/5/12 | Option/Short | No/Yes | Trades | 52 | Volume | 13,557 | Change | -2.68% |
뉴스 로딩 중...